Results 211 to 220 of about 100,641 (375)

Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia [PDF]

, 2018
Elizabeth Brigham, Tom H. Johnston, Carl D. Brown, Jonathon Holt, Susan H. Fox, Michael P. Hill, Patrick A. Howson, Jonathan M. Brotchie, Jack Nguyen   +8 more
openalex   +1 more source

Excess risk of fracture in incident Parkinson's disease Medicare beneficiaries. [PDF]

Inj Epidemiol
Camacho-Soto A, Faust IM, Krzyzanowski B, Killion JA, Beyene KM, Ellerbeck EF, Sosnoff JJ, Racette BA.   +7 more
europepmc   +1 more source

Severity‐Based and Family‐Centered Approaches to Deep Brain Stimulation in GNAO1‐Related Disorders

Movement Disorders Clinical Practice, EarlyView.
Jana Domínguez‐Carral, Juan Darío Ortigoza‐Escobar   +1 more
wiley   +1 more source

Differentiating effects of levodopa and subthalamic nucleus deep brain stimulation on motor features in Parkinson disease. [PDF]

Clin Park Relat Disord
Lee TA, Ramesh D, Ushe M, Norris SA, Tabbal SD, Perlmutter JS, Younce JR.   +6 more
europepmc   +1 more source

Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia

, 2017
Xuewei Zhou, Janine Doorduin, P. H. Elsinga, R.A.J.O. Dierckx, Erik F. J. de Vries, Cindy Casteels   +5 more
openalex   +2 more sources

Electrophysiological and biochemical evaluations of neuropathy risk in oral levodopa versus levodopa/carbidopa intestinal gel treatment. [PDF]

Arq Neuropsiquiatr
Erdem M, Selluncak B, Balal M, Fidanci H, Demirkiran M.   +4 more
europepmc   +1 more source

An Adverse Drug Interaction of Haloperidol with Levodopa

, 2015
JishaM Lucca, Madhan Ramesh, G Parthasarathi, Rajesh Raman   +3 more
openalex   +2 more sources

D ₁ , not D ₂ , dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa [PDF]

, 2020
Richard B. Mailman, Yang Yang, Xuemei Huang   +2 more
openalex   +1 more source

Temporal Dynamics of Beta Power Related to the Stun Effect in Parkinson's Disease Patients after Deep Brain Stimulation Surgery

Movement Disorders, EarlyView.
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for patients with advanced Parkinson's disease (PD). Early programming of DBS may be complicated by the postoperative “stun effect,” which also may impact local field potentials (LFPs). Methods Percept PC neurostimulators (Medtronic) were used to
Martijn G.J. de Neeling, Stijn Geraats, Bart E.K.S. Swinnen, Mariëlle J. Stam, Rob M.A. de Bie, Bernadette C.M. van Wijk, P. Rick Schuurman, Arthur W.G. Buijink, Martijn Beudel   +8 more
wiley   +1 more source

The Effect of Dopaminergic Therapies in Parkinson's Disease on Non-Motor Symptoms. [PDF]

Int J Mol Sci
Jampolska M, Kaczyńska K.
europepmc   +1 more source